Search results for "Human health sciences"

showing 9 items of 9 documents

Making sense of big data in health research: {T}owards an {EU} action plan

2016

Genome medicine 8(1), 71 (2016). doi:10.1186/s13073-016-0323-y

0301 basic medicineBiomedical ResearchDatabases FactualPREDICTIONComputer scienceBig data: Santé publique services médicaux & soins de santé [D22] [Sciences de la santé humaine]XXBioinformaticsBases de dadesSYSTEMS MEDICINE0302 clinical medicineINFORMATICSCultural diversityHealth careGenetics(clinical)030212 general & internal medicineGenetics (clinical)media_commonGenetics & HeredityExabyteCHALLENGESMacrodadesCANCER3. Good healthAction planMolecular MedicineErratumLife Sciences & BiomedicineMedical GeneticsOpinion: Public health health care sciences & services [D22] [Human health sciences]MedicinaInformation DisseminationMECHANISMS03 medical and health sciencesFUTUREJournal ArticleGeneticsmedia_common.cataloged_instanceHumansKNOWLEDGEEuropean UnionEuropean unionMolecular BiologyMedicinsk genetik0604 GeneticsScience & Technologybusiness.industryInformation DisseminationHealth Plan Implementation1103 Clinical SciencesCAREData scienceData sharing030104 developmental biologyUNDIAGNOSED DISEASES NETWORKbusiness
researchProduct

Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure

2015

Background— Clinical trials in heart failure have focused on the improvement in symptoms or decreases in the risk of death and other cardiovascular events. Little is known about the effect of drugs on the risk of clinical deterioration in surviving patients. Methods and Results— We compared the angiotensin-neprilysin inhibitor LCZ696 (400 mg daily) with the angiotensin-converting enzyme inhibitor enalapril (20 mg daily) in 8399 patients with heart failure and reduced ejection fraction in a double-blind trial. The analyses focused on prespecified measures of nonfatal clinical deterioration. In comparison with the enalapril group, fewer LCZ696-treated patients required intensification of med…

Angiotensin receptorVascular damage Radboud Institute for Health Sciences [Radboudumc 16]receptorsTetrazolesheart failureAngiotensin-Converting Enzyme InhibitorsKaplan-Meier EstimateSacubitrilAngiotensin; Heart failure; Neprilysin; Receptors; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Double-Blind Method; Enalapril; Heart Failure; Humans; Kaplan-Meier Estimate; Natriuretic Peptide Brain; Neprilysin; Peptide Fragments; Risk Factors; Stroke Volume; Survivors; Tetrazoles; Treatment Outcome; Troponin; Disease Progression; Medicine (all); Cardiology and Cardiovascular Medicine; Physiology (medical)AngiotensinEnalaprilRisk FactorsEnalapril/therapeutic useNatriuretic Peptide BrainHeart Failure/bloodSurvivorsReceptorNeprilysinAminobutyrates: Systèmes cardiovasculaire & respiratoire [D03] [Sciences de la santé humaine]Troponin/bloodTroponinAngiotensin Receptor Antagonists/therapeutic useDrug CombinationsAngiotensin-Converting Enzyme Inhibitors/therapeutic useTreatment OutcomeTetrazoles/therapeutic useCardiologyDisease ProgressionValsartanNeprilysinHeart Failure/blood/drug therapy/physiopathologyCardiology and Cardiovascular Medicinemedicine.drugReceptormedicine.medical_specialtyHeart failureneprilysinAngiotensin Receptor Antagonistsreceptors angiotensinDouble-Blind MethodPhysiology (medical)Internal medicineRenin–angiotensin systemmedicineHumansheart failure neprilysin receptors angiotensinEnalaprilbusiness.industryBiphenyl CompoundsStroke Volumemedicine.diseasePeptide FragmentsEndocrinologyAminobutyrates/therapeutic useStroke Volume/physiologyHeart failureNatriuretic Peptide Brain/blood: Cardiovascular & respiratory systems [D03] [Human health sciences]businessNeprilysin/antagonists & inhibitorsPeptide Fragments/bloodSacubitril ValsartanBiomarkersBiomarkers/blood
researchProduct

Cardiac threat appraisal and depression after first myocardial infarction

2012

The present study investigated cardiac threat appraisal and its association with depression after first myocardial infarction (MI). A semi-structured interview allowing for DSM-IV-Axis I diagnoses was administered to 36 patients after first MI. Patients completed self-reports 5 to 15 days after the MI (time 1), 6 to 8 weeks later (time 2) and again 6 months later (time 3). Assessments at time 1 included indices of cardiac threat appraisal, locus of control, coping, and depression while at time 2 and time 3 only measures of depression were obtained. Cardiac threat appraisal was significantly correlated with depression at time 1, but was unrelated to depression scores at time 2 and time 3. Fu…

Coping (psychology)medicine.medical_specialtylcsh:BF1-990Myocardial InfarctionIllness AdaptationFirst myocardial infarction: Theoretical & cognitive psychology [H12] [Social & behavioral sciences psychology]: Traitement & psychologie clinique [H13] [Sciences sociales & comportementales psychologie]: Treatment & clinical psychology [H13] [Social & behavioral sciences psychology]Cardiac Threat AppraisalCoping with myocardial infarction: Psychologie animale éthologie & psychobiologie [H01] [Sciences sociales & comportementales psychologie]medicinePsychologyMyocardial infarctionPsychiatryPractical implicationsGeneral PsychologyDepressive symptoms: Psychologie cognitive & théorique [H12] [Sciences sociales & comportementales psychologie]Original Research: Psychiatry [D21] [Human health sciences]: Psychiatrie [D21] [Sciences de la santé humaine]business.industryDepression: Neurosciences & comportement [H07] [Sciences sociales & comportementales psychologie]medicine.diseaseLocus of controllcsh:Psychology: Neurosciences & behavior [H07] [Social & behavioral sciences psychology]: Animal psychology ethology & psychobiology [H01] [Social & behavioral sciences psychology]business
researchProduct

A look into the future of the COVID-19 pandemic in Europe : an expert consultation

2021

How will the coronavirus disease 2019 (COVID-19) pandemic develop in the coming months and years? Based on an expert survey, we examine key aspects that are likely to influence COVID-19 in Europe. The future challenges and developments will strongly depend on the progress of national and global vaccination programs, the emergence and spread of variants of concern, and public responses to nonpharmaceutical interventions (NPIs). In the short term, many people are still unvaccinated, VOCs continue to emerge and spread, and mobility and population mixing is expected to increase over the summer. Therefore, policies that lift restrictions too much and too early risk another damaging wave. This ch…

Delphi methodPsychological intervention: Multidisciplinaire généralités & autres [F99] [Sciences du vivant]0302 clinical medicineCOVID-19 (Disease) -- Risk factors -- EuropePandemic030212 general & internal medicine: Multidisciplinary general & others [D99] [Human health sciences]0303 health sciencesEurope policy adviceHealth PolicyPublic Health Global Health Social Medicine and EpidemiologyOther Quantitative Biology (q-bio.OT)Quantitative Biology - Other Quantitative Biology3. Good healthCoronavirus infections -- EuropeVaccinationEuropegroup forecastOncologyCOVID-19 (Disease) -- Vaccination -- EuropePublic aspects of medicineRA1-1270: Immunology & infectious disease [D12] [Human health sciences]Coronavirus disease 2019 (COVID-19): Multidisciplinaire généralités & autres [D99] [Sciences de la santé humaine]610: Multidisciplinary general & others [F99] [Life sciences]variants of concernexpert survey03 medical and health sciencesViewpointSocial distancing (Public health) and education -- EuropeIntensive careDevelopment economicsInternal MedicineCOVID-19 (Disease) -- Europeddc:610non-pharmaceutical interventions030304 developmental biologypolicy adviceSARS-CoV-2Population mixingCOVID-19 Pandemic 2020- -- EuropeCOVID-19Expert consultationDelphi studyFolkhälsovetenskap global hälsa socialmedicin och epidemiologi: Immunologie & maladie infectieuse [D12] [Sciences de la santé humaine]FOS: Biological sciencesBusinessHuman medicine
researchProduct

Item response theory and differential test functioning analysis of the HBSC-Symptom-Checklist across 46 countries

2022

Abstract Background The Symptom Checklist (SCL) developed by the Health Behaviour in School-aged Children (HBSC) study is a non-clinical measure of psychosomatic complaints (e.g., headache and feeling low) that has been used in numerous studies. Several studies have investigated the psychometric characteristics of this scale; however, some psychometric properties remain unclear, among them especially a) dimensionality, b) adequacy of the Graded Response Model (GRM), and c) measurement invariance across countries. Methods Data from 229,906 adolescents aged 11, 13 and 15 from 46 countries that participated in the 2018 HBSC survey were analyzed. Adolescents were selected using representative s…

HBSC symptom checklistHealth behaviour in school‑aged childrenAdolescentPsychometrics: Public health health care sciences & services [D22] [Human health sciences]EpidemiologyEmotionskyselytutkimuslapset (ikäryhmät): Santé publique services médicaux & soins de santé [D22] [Sciences de la santé humaine]Health InformaticsAdolescentsnuoretmielenterveysSurveys and QuestionnairesHumansChildreliabiliteettiMeasurement invarianceSchoolsCross-nationalSubjective health complaintsReproducibility of ResultsPsychosomatic health complaintsChecklistpsykometriikkaSelf‑reported health complaintsvaliditeettimittarit (mittaus)psykosomatiikkaDifferential item functioningBMC Medical Research Methodology
researchProduct

Generation of a novel next-generation sequencing-based method for the isolation of new human papillomavirus types

2018

Immunology & infectious diseaseHuman health sciencesSciences de la santé humaineImmunologie & maladie infectieuse
researchProduct

Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.

2014

Importance The disease process leading to clinical type 1 diabetes often starts during the first years of life. Early exposure to complex dietary proteins may increase the risk of β-cell autoimmunity in children at genetic risk for type 1 diabetes. Extensively hydrolyzed formulas do not contain intact proteins. Objective To test the hypothesis that weaning to an extensively hydrolyzed formula decreases the cumulative incidence of diabetes-associated autoantibodies in young children. Design, Setting, and Participants A double-blind randomized clinical trial of 2159 infants with HLA-conferred disease susceptibility and a first-degree relative with type 1 diabetes recruited from May 2002 to Ja…

Maleinsulin-Secreting CellsautoantibodiesAutoimmunity2700 General MedicineGastroenterologylaw.invention0302 clinical medicineRandomized controlled trialnewbornlawCaseindouble-blind methodCumulative incidence030212 general & internal medicinehumans: Multidisciplinary general & others [D99] [Human health sciences]childHazard ratioGeneral Medicinefollow-up studiesInfant Formulaanimalscaseinstype 1femaleMilkbreast feedinghydrolysisdiabetes mellitusRiskmedicine.medical_specialty: Multidisciplinaire généralités & autres [D99] [Sciences de la santé humaine]β-cell autoimmunity610 Medicine & health030209 endocrinology & metabolismWeaningArticlehydrolyzed infant formula03 medical and health sciencesInternal medicineDiabetes mellitusHydrolyzed infant formula and early β-cell autoimmunitymedicineanimals; autoantibodies; breast feeding; caseins; child; diabetes mellitus; type 1; dietary proteins; double-blind method; female; follow-up studies; humans; hydrolysis; incidence; infant; newborn; insulin-Secreting Cells; Male; Milk; Risk; Weaning; Autoimmunity; Infant FormulaType 1 diabetesbusiness.industrydietary proteinsta1183Infant Newbornmedicine.diseaseta3123infantDiabetes Mellitus Type 1EndocrinologyInfant formula10036 Medical ClinicincidencebusinessBreast feeding
researchProduct

European fitness landscape for children and adolescents: updated reference values, fitness maps and country rankings based on nearly 8 million test r…

2023

Objectives (1) To develop reference values for health-related fitness in European children and adolescents aged 6–18 years that are the foundation for the web-based, open-access and multilanguage fitness platform (FitBack); (2) to provide comparisons across European countries. Methods This study builds on a previous large fitness reference study in European youth by (1) widening the age demographic, (2) identifying the most recent and representative country-level data and (3) including national data from existing fitness surveillance and monitoring systems. We used the Assessing Levels of PHysical Activity and fitness at population level (ALPHA) test battery as it comprises tests with the h…

Settore M-EDF/01 - Metodi e Didattiche delle Attivita' Motorie: Multidisciplinaire généralités & autres [D99] [Sciences de la santé humaine]Physical Therapy Sports Therapy and RehabilitationGeneral Medicineyouth norms physical testingphysical fitness; children; adolescent; europe;Athletic & outdoor sports & gameschildrenadolescentMedicine and Health Sciencesphysical fitnessOrthopedics and Sports Medicineddc:796europephysical endurance: Multidisciplinary general & others [D99] [Human health sciences]
researchProduct

Cross-national time trends in adolescent body weight perception and the explanatory role of overweight/obesity prevalence

2023

Introduction Body weight perception (BWP) is associated with health behaviors. Current evidence points to an increase over time in both actual and perceived weight status among adolescents, however there is limited evidence on time trends in BWP in cross-national samples of adolescents. Therefore, the aims of this study were to examine time trends in BWP between 2002 and 2018 among adolescents from 41 countries and regions, including gender and country differences and to explore the role of changes over time in country-level overweight/obesity prevalence in these trends. Methods Data were used from five cycles (2002, 2006, 2010, 2014, 2018) of the repeated cross-sectional Health Behavior in…

trendsobesityteini-ikäisetweight perception: Pédiatrie [D19] [Sciences de la santé humaine]body weight congruence: Pediatrics [D19] [Human health sciences]asenteetylipainotrenditsukupuolinuoretterveyskäyttäytyminenkokemuksetoverweightlihavuusadolescents
researchProduct